Delivery Order SPE2DB22D2206-SPE2DB24FJT76

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,022.34 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4565803453 NEOMYC-POLYM-DEXAMETH EYE DROP 5ML. This award is a part of DLA's larger indefinite delivery contract (IDC) valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NEOMYC-POLYM-DEXAMETH EYE DROP 5ML, a pharmaceutical product. The contract has a firm fixed price of $1,505.43 and a period of performance through April 18, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp also holds a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Neomycin-Polymyxin-Hydrocortisone eye drops. The contract has a total ceiling value of $3,088.52 and an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medical products and supplies to support various government agencies and healthcare programs, including...
This federal contract award is for the delivery of Neomycin-Poly-HC eye drops, 7.5 mL, to the Defense Logistics Agency (DLA). The contract, valued at $1,143.07, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range...
This is a $1,354.91 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NEOMYC-POLYM-GRAMICID EYE DROP 10ML, a medical product. The contract has a period of performance through January 17, 2024. This contract award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,599.07 firm fixed-price delivery order is for the supply of NEOMYC-POLYM-GRAMICID EYE DROP 10ML, a type of prescription medication. The contract has an ultimate completion date of September 27, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract without any set-aside designation. The company holds...
This federal contract award, with the ID SPE2DB20D1004|SPE2DB25FNEDY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.98, is for the delivery of a 0.1% eye drop medication in 2ml vials. This is a Firm Fixed Price Delivery Order contract, with a completion date of January 15, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $4,577.85 issued by the Defense Logistics Agency (DLA). It covers the procurement of 0.1% eye drop medication, 2ml size, with a completion date of January 6, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary contracting vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,375.12, is for the delivery of NEOMYC-BACIT-POLYMIX EYE OINTMENT 3.5GM. It is a firm-fixed-price delivery order contract with a completion date of December 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,189.06 firm-fixed-price delivery order is for the supply of MIEBO 100% Eye Drop 3ML, a medical product, with a completion date of December 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJT76
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Neomycin-Polymyxin-Dexamethasone eye drops with a ceiling value of $1,392.27. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation. Amerisourcebergen, through its extensive supply chain and distribution capabilities, will be delivering this critical pharmaceutical product to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 11/12/24, 9:01 AM